Antineoplastic Combined Chemotherapy Protocols

Known as: Drug Combinations, Antineoplastic, Agents, Combined Antineoplastic, Antineoplastic Drug Combination 
The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form.
National Institutes of Health

Topic mentions per year

Topic mentions per year

1972-2018
02419722018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
UNLABELLED Small-molecule drug combination therapies are an attractive approach to enhancing cancer chemotherapeutic responses… (More)
Is this relevant?
2010
2010
There is an opportunity to improve the therapeutic potential of a combination of two drugs using nanoliposomes. The combination… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
We demonstrate here that cytarabine and daunorubicin, a standard drug combination used in the treatment of leukaemia, exhibits… (More)
Is this relevant?
2009
2009
Arsenicand platinum-based drugs are highly potent but also toxic agents used in cancer therapy. Arsenic trioxide (Trisenox, As2O3… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2009
2009
Identifying effective drug combinations that significantly improve over single agents is a challenging problem. Pairwise… (More)
  • table 1
  • table 2
  • figure 3
Is this relevant?
2007
2007
Whether anticancer drug combinations act synergistically or antagonistically often depends on the ratio of the agents being… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Anticancer drug combinations can act synergistically or antagonistically against tumor cells in vitro depending on the ratios of… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
2006
2006
TRAIL (TNF-alpha-Related Apoptosis-Inducing Ligand) is a promising anticancer agent. In fact, it induces apoptosis in cancer… (More)
Is this relevant?
2006
2006
To better understand and design microsphere systems for the locoregional delivery of anticancer drug combinations to solid tumors… (More)
Is this relevant?
2005
2005
PURPOSE We have recently shown that combination of tumor necrosis factor alpha-related apoptosis-inducing ligand (TRAIL) with… (More)
Is this relevant?